New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 1, 2013
12:38 EDTANF, HLF, HAIN, RPRX, EQIXOptions with increasing implied volatility: RPRX HLF EQIX HAIN ANF
News For RPRX;HLF;EQIX;HAIN;ANF From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
November 20, 2015
07:39 EDTANFAbercrombie & Fitch reports Q3 adj. EPS 48c, may not compare to consensus 22c
Subscribe for More Information
November 19, 2015
15:24 EDTANFNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Foot Locker (FL), consensus 94c... Sirona Dental (SIRO), consensus $1.10... Abercrombie & Fitch (ANF), consensus 22c... Hibbett Sport (HIBB), consensus 68c.
14:51 EDTANFAbercrombie & Fitch November 19 straddle priced for 12% movement into Q3
14:26 EDTANFAbercrombie & Fitch technical comments ahead of earnings
The shares have been trading in a sideways but wide range since March of this year. Shares ahead of earnings are currently trading below an important support level, $20, which has held for most of this sideways trading period. A move back above $20 on good news would be a technical positive that could see the highs of the recent range tested. The first resistance level of significance is at the 30-day moving average at $20.93. The 30-day has nearly flattened out in recent months, bisecting the range. Next resistance above the 30-day would be at $21.68, $22.25, and $23.25. If the news is bearish, the shares could drift to the low end of the range. First support would be at $18.74. Below that support, additional downside objectives may be at $17.60 and $16.56. The 52-week low is at $15.42.
13:29 EDTANFEarnings Watch: Abercrombie reports amid ongoing turnaround, CEO search
Abercrombie & Fitch (ANF) is scheduled to report third quarter earnings before the market open on Friday, November 20 with a conference call scheduled for 8:30 am ET. Abercrombie & Fitch is a retailer of casual apparel for men, women and kids. EXPECTATIONS: Analysts are looking for earnings per share of 22c on revenue of $864.65M, according to First Call. The consensus range for EPS is 7c-44c on revenue of $832.7M-$897M. LAST QUARTER: On August 26, Abercrombie & Fitch reported second quarter adjusted EPS of 12c on revenue of $817.8M, beating consensus estimates of (4c) and $811.46M, respectively. The company added that same store sales for Q2 were down 4% year over year. Abercrombie & Fitch also said that it expected same store sales trends to improve in the second half of the year, skewed towards the fourth quarter. NEWS: The company said in its Q2 earnings release that it planned to open 15 full-price stores in fiscal 2015 in China, Japan, and the Middle East, six full price stores in North America, and ten new outlet stores in the U.S. The retailer also said that it expected to close roughly 60 stores in the U.S. during the fiscal year through natural lease expirations. On its Q2 conference call, Abercrombie & Fitch said that its board was "deeply engaged" in its search for a new chief executive officer and that someone will be appointed to the role "in due time." The company added on the call that it was still making adjustments to prices at the Abercrombie brand. STREET RESEARCH: On August 27, Stifel upgraded Abercrombie to Buy from Hold and maintained a $24 price target following the company's upbeat Q2 results. A day later, RBC Capital upgraded the company's stock to Sector Perform from Underperform and raised its price target to $20 from $17, saying that the fundamentals of the Hollister unit are improving while revenue was showing signs of rebounding. On September 24, Standpoint Research downgraded Abercrombie & Fitch to Hold from Buy. On October 19, Wunderlich upgraded the company's shares to Hold from Sell with a $21 price target, saying that there were signs of a business turnaround. On November 19, Susquehanna reiterated a Positive rating and $26 price target on the retailer's stock, saying it believes the company is well positioned for the holiday season. PRICE ACTION: Abercrombie & Fitch shares are flat at $19.75 in afternoon trading ahead of tomorrow's earnings report. The stock is up about 12.5% over the past three months.
08:38 EDTANFAbercrombie & Fitch well positioned for holidays, says Susquehanna
Subscribe for More Information
06:03 EDTEQIXEquinix 2.6M share Secondary priced at $288
JPMorgan, BofA/Merrill, Citi, RBC Capital, Barclays and TD Securities acted as joint book running managers for the offering.
November 18, 2015
09:06 EDTHAINHain Celestial weakness looks overdone, says Bernstein
Bernstein notes that Hain Celestial (HAIN) is now trading at a lower valuation than a number of "ostensibly more challenged food companies like" Kellogg (K) and General Mills (GIS). The firm expects the company to benefit over the longer term from current food trends. It trimmed its price target on the name to $50 from $60 and keeps an Outperform rating.
November 17, 2015
16:42 EDTHLFJustice Department announces criminal charges against supplement maker USPlabs
The U.S. Department of Justice, along with partners at the Food and Drug Administration, Federal Trade Commission, Postal Inspection Service, and Internal Revenue Service, announced a "nationwide sweep" targeting more than 100 makers and marketers of dietary supplements. The agencies noted, "The actions discussed today resulted from a year-long effort, beginning in November 2014, to focus enforcement resources in an area of the dietary supplement market that is causing increasing concern among health officials nationwide. In each case, the department or one of its federal partners allege the sale of supplements that contain ingredients other than those listed on the product label or the sale of products that make health or disease treatment claims that are unsupported by adequate scientific evidence." Among the cases announced Tuesday is a criminal case charging USPlabs and several of its corporate officers with various counts associated with the unlawful sale of dietary supplements, obstruction of an FDA proceeding, and conspiracy to commit money laundering. The Department also filed in the past week five civil cases seeking injunctive relief against a number of businesses and individuals that allegedly sold supplements as disease cures or that were otherwise in violation of the law. The cases involve various entities, including Vibrant Life, Viruxo, Optimum Health, Bethel Nutritional, VivaCeuticals, and Regeneca, said the agency. Note that shares of GNC (GNC), Herbalife (HLF), Vitamin Shoppe (VSI), and Natural Health (NHTC) all slipped Tuesday following early reports of criminal charges in the dietary supplement space. Reference Link
15:10 EDTHLFDOJ files indictment against USPLabs over Supplements, FDA Law Blog says
Shares of GNC Holdings (GNC), Vitamin Shoppe (VSI), and Herbalife (HLF) were all weak this afternoon on concerns that they would be the target of the FDA's action. Reference Link
14:46 EDTANFAbercrombie & Fitch volatility elevated into Q3 and outlook
Subscribe for More Information
13:09 EDTHLFHerbalife says not aware of being named in DOJ supplement action, Bloomberg says
Subscribe for More Information
12:35 EDTHLFHerbalife puts active on headlines of DOJ briefing on supplement actions
Herbalife November 47 and 50 puts are active on total put volume of 9,800 contracts (2,400 calls) following Bloomberg headlines of DOJ briefing on supplement actions. November put option implied volatility is at 113, December is at 55; compared to its 52-week range of 34 to 126. Active put volume suggests traders taking positions for wide price movement.
12:28 EDTHLFGNC, Vitamin Shoppe, Herbalife at lows following DOJ supplement advisory
The Department of Justice said in a media advisory that it plans to announce at 3:30 pm today its actions related to dietary supplements sales and unlawful ads. Following the press advisory, shares of GNC Holdings (GNC), Vitamin Shoppe (VSI) and Herbalife (HLF) are at session lows, though none of the companies were named in the advisory.
November 16, 2015
17:10 EDTHLFSoros took stake in Paypal, liquidated Herbalife stake
Soros Fund Management gave a quarterly update on its stakes in a filing this afternoon. NEW STAKES: Paypal (PYPL), CIT Group (CIT), Schlumberger (SLB), Kraft Heinz (KHC), and Amazon (AMZN). INCREASED STAKES: Allergan (AGN), Lions Gate (LGF), Energen (EGN), Southwest Airlines (LUV), and Qunar Cayman Islands (QUNR). DECREASED STAKES: LyondellBasell (LYB), YPF (YPF), Time Warner Cable (TWC), Dow Chemical (DOW), and Monsanto (MON). LIQUIDATED STAKES: Herbalife (HLF), Lennar (LEN), DR Horton (DHI), United Continental (UAL), and Nice Systems (NICE).
16:07 EDTEQIXEquinix files to sell $750M of common stock
Subscribe for More Information
10:29 EDTEQIXInvenergy to provide clean power to Equinix
Invenergy announced that it has signed a 100 MW wind power purchase agreement, PPA, with Equinix to provide the global interconnection and data center company with renewable energy to help support all of its data centers across North America. The agreement with Equinix includes the sale of wind energy from the Wake Wind Energy Facility located in Texas. Invenergy will provide 100 MW of capacity resulting in approximately 457,000 MW hours of renewable energy annually generated in Texas and delivered into the Electric Reliability Council of Texas regional electricity grid.
08:02 EDTEQIXEquinix signs power purchase agreements with NextEra Energy and Invenergy
Subscribe for More Information
November 13, 2015
10:33 EDTEQIXEquinix obtains European clearance on offer to acquire TelecityGroup
Subscribe for More Information
November 12, 2015
16:35 EDTRPRXRepros completes randomization of Phase 2b study of Vaginal Proellex
Subscribe for More Information
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use